|4Aug 6, 5:00 PM ET

Linscott Walt Addison 4

4 · Indaptus Therapeutics, Inc. · Filed Aug 6, 2021

Insider Transaction Report

Form 4
Period: 2021-08-04
Linscott Walt Addison
Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-08-04+210,000210,000 total
    Exercise: $8.87Exp: 2031-08-04Common Stock (210,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable as to one-third of the total shares on August 4, 2022 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.

Documents

1 file
  • 4
    ownership.xmlPrimary